Your browser doesn't support javascript.
loading
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.
Cowan, Robert P; Marmura, Michael J; Diener, Hans-Christoph; Starling, Amaal J; Schim, Jack; Hirman, Joe; Brevig, Thomas; Cady, Roger.
Affiliation
  • Cowan RP; Stanford Health Care, Palo Alto, CA, USA.
  • Marmura MJ; Jefferson Headache Center, Philadelphia, PA, USA.
  • Diener HC; Medical Faculty of the University Duisburg-Essen, Institute for Medical Informatics, Biometry and Epidemiology, Essen, Germany.
  • Starling AJ; Mayo Clinic Arizona, Scottsdale, AZ, USA.
  • Schim J; The Neurology Center of Southern California, Carlsbad, CA, USA.
  • Hirman J; Pacific Northwest Statistical Consulting, Inc., Woodinville, WA, USA.
  • Brevig T; H. Lundbeck A/S, Valby, Denmark.
  • Cady R; Lundbeck LLC, Deerfield, IL, USA. rcady@rkconsults.com.
J Headache Pain ; 23(1): 115, 2022 Sep 06.
Article in En | MEDLINE | ID: mdl-36068494
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Headache Disorders, Secondary / Acute Pain / Migraine Disorders Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: J Headache Pain Journal subject: MEDICINA INTERNA / NEUROLOGIA / PSICOFISIOLOGIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Headache Disorders, Secondary / Acute Pain / Migraine Disorders Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: J Headache Pain Journal subject: MEDICINA INTERNA / NEUROLOGIA / PSICOFISIOLOGIA Year: 2022 Type: Article Affiliation country: United States